Status:
NOT_YET_RECRUITING
Analgesic Efficacy of Intrathecal Fentanyl-Morphine Combination Versus Morphine Alone for Intraoperative Pain During Elective Cesarean Delivery
Lead Sponsor:
Seoul National University Hospital
Conditions:
Intraoperative Pain
Eligibility:
FEMALE
19-99 years
Phase:
PHASE4
Brief Summary
Pregnant women scheduled for elective cesarean sections under spinal anesthesia are randomly assigned to two groups: 1) the Fentanyl-Morphine (FM) group, and 2) the Morphine (M) group. In addition to ...
Eligibility Criteria
Inclusion
- Parturients of gestational age \> 37 weeks, scheduled for cesarean section under spinal anesthesia
Exclusion
- Contraindication to spinal anesthesia
- Any sign of onset of labor
- Emergency cesarean section
- Body weight \< 40 kg or \> 120 kg
- Height \< 140 cm or \> 190 cm
- Severe underlying cardiovascular disease
- Known fetal anomaly
- Preeclampsia
- History of hypersensitivity to fentanyl or morphine
- Chronic opioid use
Key Trial Info
Start Date :
September 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 25 2025
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT06570343
Start Date
September 20 2024
End Date
December 25 2025
Last Update
October 1 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.